circulating tumor biomarker detection

EValuate Diagnostics is working to facilitate the detection of disease, with an emphasis on cancers, by establishing the least invasive testing methods with the greatest accuracy. The company harnesses circulating extracellular vesicles to detect circulating tumor biomarkers early, developing a novel non-invasive method of surveillance. It was created as the first spin-off company of Hackensack Meridian Health Research Institute.

Read more

companion diagnosticsearly non-invasive disease detectionextracellular vesicle purification and isolationin vitro diagnosticsresearch services